Cargando…

Epigenetic regulation of the human telomerase reverse transciptase gene: A potential therapeutic target for the treatment of leukemia (Review)

Telomerase activation is a critical step in human carcinogenesis through the maintenance of telomeres. Telomerase activity is primarily regulated by the human telomerase reverse transcriptase gene (hTERT), thus, an improved understanding of the transcriptional control of hTERT may provide potential...

Descripción completa

Detalles Bibliográficos
Autores principales:	SUI, XINBING, KONG, NA, WANG, ZHANGGUI, PAN, HONGMING
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2013
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789043/ https://www.ncbi.nlm.nih.gov/pubmed/24137323 http://dx.doi.org/10.3892/ol.2013.1367

Ejemplares similares

Autophagy: A novel therapeutic target for hepatocarcinoma (Review)
por: WANG, ZHANGGUI, et al.
Publicado: (2014)

Telomerase reverse transcriptase moonlights: Therapeutic targets beyond telomerase
por: Maida, Yoshiko, et al.
Publicado: (2015)

Regulation of the Telomerase Reverse Transcriptase Subunit through Epigenetic Mechanisms
por: Lewis, Kayla A., et al.
Publicado: (2016)

The role of STAT3 in autophagy
por: You, Liangkun, et al.
Publicado: (2015)

Telomerase Reverse Transcriptase (TERT) in Action: Cross-Talking with Epigenetics
por: Yuan, Xiaotian, et al.
Publicado: (2019)

Telomerase Regulation: A Role for Epigenetics
por: Dogan, Fatma, et al.
Publicado: (2021)

Exploring the epigenetic regulation of telomerase reverse transcriptase (TERT) in human cancer cell lines
por: McKelvey, Brittany A., et al.
Publicado: (2020)

Therapeutic Targeting of Telomerase
por: Jäger, Kathrin, et al.
Publicado: (2016)

Mechanism of Human Telomerase Reverse Transcriptase (hTERT) Regulation and Clinical Impacts in Leukemia
por: Yik, Mot Yee, et al.
Publicado: (2021)

Nec-1 Enhances Shikonin-Induced Apoptosis in Leukemia Cells by Inhibition of RIP-1 and ERK1/2
por: Han, Weidong, et al.
Publicado: (2012)

Targeting telomerase for cancer therapeutics
por: Shay, J W, et al.
Publicado: (2008)

p53-induced autophagy and senescence
por: Sui, Xinbing, et al.
Publicado: (2015)

Telomerase reverse transcriptase in the regulation of gene expression
por: Zhou, Junzhi, et al.
Publicado: (2014)

Telomerase Reverse Transcriptase Regulates microRNAs
por: Lassmann, Timo, et al.
Publicado: (2015)

Human Telomerase Reverse Transcriptase as a Therapeutic Target of Dihydroartemisinin for Esophageal Squamous Cancer
por: Li, Qingrong, et al.
Publicado: (2021)

Medical genetics and epigenetics of telomerase
por: Koziel, Jillian E, et al.
Publicado: (2011)

Epigenetic Regulators in the Development, Maintenance, and Therapeutic Targeting of Acute Myeloid Leukemia
por: Sun, Younguk, et al.
Publicado: (2018)

Autophagy inhibition sensitizes hepatocellular carcinoma to the multikinase inhibitor linifanib
por: Pan, Hongming, et al.
Publicado: (2014)

Author Correction: Autophagy inhibition sensitizes hepatocellular carcinoma to the multikinase inhibitor linifanib
por: Pan, Hongming, et al.
Publicado: (2020)

Human Specific Regulation of the Telomerase Reverse Transcriptase Gene
por: Zhang, Fan, et al.
Publicado: (2016)

Transcriptional Regulation of Telomerase Reverse Transcriptase (TERT) by MYC
por: Khattar, Ekta, et al.
Publicado: (2017)

Regulation and clinical potential of telomerase reverse transcriptase (TERT/hTERT) in breast cancer
por: Yang, Ruozhu, et al.
Publicado: (2023)

Reversal of brain aging by targeting telomerase: A nutraceutical approach
por: Tsoukalas, Dimitris, et al.
Publicado: (2021)

Mitochondrial Telomerase Reverse Transcriptase, a Target for Cardiovascular Disease?
por: Torimoto, Keiichi, et al.
Publicado: (2022)

Telomerase Reverse Transcriptase (TERT) is a Therapeutic Target of Oleanane Triterpenoid CDDO-Me in Prostate Cancer
por: Liu, Yongbo, et al.
Publicado: (2012)

Telomerase reactivation reverses tissue degeneration in aged telomerase deficient mice
por: Jaskelioff, Mariela, et al.
Publicado: (2010)

Emerging Epigenetic Therapeutic Targets in Acute Myeloid Leukemia
por: Wingelhofer, Bettina, et al.
Publicado: (2019)

Telomerase as a Target for Therapeutic Cancer Vaccines and Considerations for Optimizing Their Clinical Potential
por: Ellingsen, Espen Basmo, et al.
Publicado: (2021)

Multiple Actions of Telomerase Reverse Transcriptase in Cell Death Regulation
por: Palamarchuk, Anastasia I., et al.
Publicado: (2023)

Diabetic retinopathy: reversibility of epigenetic modifications and new therapeutic targets
por: Zhang, Xinyuan, et al.
Publicado: (2017)

Telomerase reverse transcriptase and neurodegenerative diseases
por: Yu, Xin, et al.
Publicado: (2023)

Expression of telomerase-associated protein 1 and telomerase reverse transcriptase in hepatocellular carcinoma
por: Toshikuni, N, et al.
Publicado: (2000)

Expression of Telomerase Catalytic Component, Telomerase Reverse Transcriptase, in Human Gastric Carcinomas
por: Yasui, Wataru, et al.
Publicado: (1998)

Nuclear Shp-2 keeps telomerase reverse transcriptase in the nucleus – new potential anti-aging target
por: Jakob, S, et al.
Publicado: (2009)

Telomerase: a breast cancer chemopreventive and therapeutic target
por: Shay, JW
Publicado: (2000)

Telomerase reverse transcriptase and telomeric-repeat binding factor protein 1 as regulators of telomerase activity in pancreatic cancer cells
por: Yajima, T, et al.
Publicado: (2001)

Nuclear Receptors as Potential Therapeutic Targets for Myeloid Leukemia
por: Pan, Pan, et al.
Publicado: (2020)

Hedgehog Signaling Regulates Telomerase Reverse Transcriptase in Human Cancer Cells
por: Mazumdar, Tapati, et al.
Publicado: (2013)

Transcription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene
por: Ramlee, Muhammad Khairul, et al.
Publicado: (2016)

Telomerase Reverse Transcriptase (TERT) Regulation in Thyroid Cancer: A Review
por: McKelvey, Brittany A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2p7sft05fmmej0k2slqoerfki5